Development, Validation, and Regulatory Considerations for a Liquid Biopsy Test

Clin Chem. 2020 Mar 1;66(3):408-414. doi: 10.1093/clinchem/hvaa010.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Circulating Tumor DNA / analysis
  • ErbB Receptors / genetics
  • Government Regulation
  • Humans
  • Liquid Biopsy / methods*
  • Neoplasms / pathology
  • Neoplastic Cells, Circulating / metabolism
  • Neoplastic Cells, Circulating / pathology
  • Proto-Oncogene Proteins p21(ras) / genetics

Substances

  • Biomarkers, Tumor
  • Circulating Tumor DNA
  • KRAS protein, human
  • ErbB Receptors
  • Proto-Oncogene Proteins p21(ras)